跳至主要内容
临床试验/NL-OMON51253
NL-OMON51253撤回不适用

Functional gait training as complementary treatment to botulinum toxin type A in patients with disabling dystonia due to Parkinson*s disease: a double-blind randomized controlled clinical trial. - Gait training as complementary treatment in patients with dystonia.

Radboud Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • The main inclusion criterium consists of idiopathic Parkinson*s disease and the
  • presence of dystonia resulting in varus tilt of the hindfoot when walking. In
  • addition, participants should be able to walk 100 meters and be able to follow
  • instructions.

排除标准

  • Participants will be excluded if they:
  • Have severe cognitive impairments
  • Have other neurologic or orthopedic impairments that cause problems when
  • Are not able to walk 100 meters independently

研究者

相似试验